3839.HK
Strong BuyFull HouseAI screen passCPBIO Holding Company Limited · Healthcare · Hong Kong · $249M
HKD 7.91 -0.4% · close 5 Oct · scored 6 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Company shows balanced Quality, Value, and Momentum scores above the 60 threshold, demonstrating eligibility under internal rules. Without adverse regulatory signals, it qualifies as a stable contributor to a diversified portfolio.
ABOUT CPBIO HOLDING COMPANY LIMITED
Read
Chia Tai Enterprises International Limited manufactures and sells veterinary products, primarily chlortetracycline, and distributes industrial equipment in China. As a subsidiary of the Charoen Pokphand Group, the company leverages global distribution networks and strong brand recognition in the agricultural sector. It holds a leading market position in the global animal health market for feed-additive antibiotics.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.4B | 2.4B | 4.2B | 49.9% | 3.3B |
| EPS (HKD) | -0.21 | 0.08 | 0.35 | 0.99 | 253.9% | 0.76 |
| Shares | 240.7M | 240.7M | 240.7M | 240.7M | 0.0% | 240.7M |
| Debt | 385.3M | 613.4M | 542.7M | 375.6M | -0.8% | 593.0M |
| Equity | 1.8B | 1.8B | 1.8B | 2.2B | 6.3% | — |
| Op CF | 44.2M | -126.0M | 88.5M | 269.4M | 82.7% | -36.1M |
| Inv CF | -122.7M | -56.0M | -72.7M | -21.9M | — | — |
| Fin CF | 81.5M | 237.2M | -55.5M | -191.3M | — | — |
Swung more than 56% of stocks we rank over the past year (45% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 3839.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 3839.HK | CPBIO Holding Company Limited(you) | $249M | 95 | Strong Buy |
| 2633.HK | Jacobson Pharma Corporation Limited | $242M | 93 | Strong Buy |
| 2348.HK | Dawnrays Pharmaceutical (Holdings) Limited | $188M | 99 | Strong Buy |
| 2161.HK | JBM (Healthcare) Limited | $172M | 90 | Strong Buy |
| 8049.HK | Jilin Province Huinan Changlong Bio-pharmacy Company Limited | $169M | 100 | Strong Buy |
| 3613.HK | Beijing Tong Ren Tang Chinese Medicine Company Limited | $582M | 93 | Strong Buy |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $91M | 92 | Strong Buy |
| 0239.HK | Pak Fah Yeow International Limited | $98M | 100 | Strong Buy |
| 2005.HK | SSY Group Limited | $1.0B | 89 | Strong Buy |
| 3320.HK | China Resources Pharmaceutical Group Limited | $3.4B | 95 | Strong Buy |
Peer medians: ROE 5.7% · P/E 10.1x · Gross margin 43.2%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.